These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38522310)
1. Encapsulation of the growth factor neurotrophin-3 in heparinised poloxamer hydrogel stabilises bioactivity and provides sustained release. Meissner S; Rees S; Nguyen L; Connor B; Barker D; Harland B; Raos B; Svirskis D Biomater Adv; 2024 May; 159():213837. PubMed ID: 38522310 [TBL] [Abstract][Full Text] [Related]
2. Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury. Zhao YZ; Jiang X; Xiao J; Lin Q; Yu WZ; Tian FR; Mao KL; Yang W; Wong HL; Lu CT Acta Biomater; 2016 Jan; 29():71-80. PubMed ID: 26472614 [TBL] [Abstract][Full Text] [Related]
3. Thermosensitive heparin-poloxamer hydrogel encapsulated bFGF and NGF to treat spinal cord injury. Hu X; Li R; Wu Y; Li Y; Zhong X; Zhang G; Kang Y; Liu S; Xie L; Ye J; Xiao J J Cell Mol Med; 2020 Jul; 24(14):8166-8178. PubMed ID: 32515141 [TBL] [Abstract][Full Text] [Related]
4. Sustained-release of FGF-2 from a hybrid hydrogel of heparin-poloxamer and decellular matrix promotes the neuroprotective effects of proteins after spinal injury. Xu HL; Tian FR; Xiao J; Chen PP; Xu J; Fan ZL; Yang JJ; Lu CT; Zhao YZ Int J Nanomedicine; 2018; 13():681-694. PubMed ID: 29440894 [TBL] [Abstract][Full Text] [Related]
5. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury. Liu D; Jiang T; Cai W; Chen J; Zhang H; Hietala S; Santos HA; Yin G; Fan J Adv Healthc Mater; 2016 Jun; 5(12):1513-21. PubMed ID: 27113454 [TBL] [Abstract][Full Text] [Related]
6. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide. Soni G; Yadav KS Pharm Dev Technol; 2014 Sep; 19(6):651-61. PubMed ID: 23879721 [TBL] [Abstract][Full Text] [Related]
7. Thermosensitive heparin-poloxamer hydrogels enhance the effects of GDNF on neuronal circuit remodeling and neuroprotection after spinal cord injury. Zhao YZ; Jiang X; Lin Q; Xu HL; Huang YD; Lu CT; Cai J J Biomed Mater Res A; 2017 Oct; 105(10):2816-2829. PubMed ID: 28593744 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid on the urokinase sustained release with a hydrogel system composed of poloxamer 407: HA/P407 hydrogel system for drug delivery. Hsieh HY; Lin WY; Lee AL; Li YC; Chen YJ; Chen KC; Young TH PLoS One; 2020; 15(3):e0227784. PubMed ID: 32160196 [TBL] [Abstract][Full Text] [Related]
9. A cocktail of growth factors released from a heparin hyaluronic-acid hydrogel promotes the myogenic potential of human urine-derived stem cells in vivo. Liu G; Wu R; Yang B; Shi Y; Deng C; Atala A; Mou S; Criswell T; Zhang Y Acta Biomater; 2020 Apr; 107():50-64. PubMed ID: 32044457 [TBL] [Abstract][Full Text] [Related]
10. A Thermosensitive Heparin-Poloxamer Hydrogel Bridges aFGF to Treat Spinal Cord Injury. Wang Q; He Y; Zhao Y; Xie H; Lin Q; He Z; Wang X; Li J; Zhang H; Wang C; Gong F; Li X; Xu H; Ye Q; Xiao J ACS Appl Mater Interfaces; 2017 Mar; 9(8):6725-6745. PubMed ID: 28181797 [TBL] [Abstract][Full Text] [Related]
11. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis. Li Z; Qu T; Ding C; Ma C; Sun H; Li S; Liu X Acta Biomater; 2015 Feb; 13():88-100. PubMed ID: 25462840 [TBL] [Abstract][Full Text] [Related]
12. Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord. Elliott Donaghue I; Tator CH; Shoichet MS Biomater Sci; 2015 Jan; 3(1):65-72. PubMed ID: 26214190 [TBL] [Abstract][Full Text] [Related]
13. Biomineralized biomimetic organic/inorganic hybrid hydrogels based on hyaluronic acid and poloxamer. Huh HW; Zhao L; Kim SY Carbohydr Polym; 2015 Aug; 126():130-40. PubMed ID: 25933531 [TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of curcumin-loaded poloxamer hydrogels as injectable depot formulations. Jose AD; Foo KL; Hu G; Ngar L; Ryda B; Jaiswal J; Wu Z; Agarwal P; Thakur SS Eur J Pharm Biopharm; 2024 Aug; 201():114372. PubMed ID: 38897552 [TBL] [Abstract][Full Text] [Related]
15. An injectable PEG hydrogel controlling neurotrophin-3 release by affinity peptides. Wang J; Youngblood R; Cassinotti L; Skoumal M; Corfas G; Shea L J Control Release; 2021 Feb; 330():575-586. PubMed ID: 33378693 [TBL] [Abstract][Full Text] [Related]
16. Heparin-poloxamer hydrogel-encapsulated rhFGF21 enhances wound healing in diabetic mice. Liu H; Zhao Y; Zou Y; Huang W; Zhu L; Liu F; Wang D; Guo K; Hu J; Chen J; Ye L; Li X; Lin L FASEB J; 2019 Sep; 33(9):9858-9870. PubMed ID: 31166803 [TBL] [Abstract][Full Text] [Related]
17. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. Cho KY; Chung TW; Kim BC; Kim MK; Lee JH; Wee WR; Cho CS Int J Pharm; 2003 Jul; 260(1):83-91. PubMed ID: 12818813 [TBL] [Abstract][Full Text] [Related]
18. Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel. Stanwick JC; Baumann MD; Shoichet MS J Control Release; 2012 Jun; 160(3):666-75. PubMed ID: 22510446 [TBL] [Abstract][Full Text] [Related]
19. Thermosensitive Poloxamer 407/Poly(Acrylic Acid) Hydrogels with Potential Application as Injectable Drug Delivery System. Boonlai W; Tantishaiyakul V; Hirun N; Sangfai T; Suknuntha K AAPS PharmSciTech; 2018 Jul; 19(5):2103-2117. PubMed ID: 29696613 [TBL] [Abstract][Full Text] [Related]
20. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. Taylor SJ; McDonald JW; Sakiyama-Elbert SE J Control Release; 2004 Aug; 98(2):281-94. PubMed ID: 15262419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]